Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing 302 Hospital
Medstar Health Research Institute
National Taiwan University Hospital
M.D. Anderson Cancer Center
Peking University
Barbara Ann Karmanos Cancer Institute
University of Arizona
Northwestern University
City of Hope Medical Center
National Taiwan University Hospital
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Scripps Health
Temple University
Case Comprehensive Cancer Center